Literature DB >> 17876851

Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease.

Andrew Siderowf1, Danna Jennings, James Connolly, Richard L Doty, Kenneth Marek, Matthew B Stern.   

Abstract

Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first-degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Idiopathic hyposmia has also been associated with an increased risk of PD. The relationship between risk factors for PD and impaired olfactory function has not been evaluated in relatives of PD patients. We conducted a mail survey of odor identification ability in 173 first-degree relatives of PD patients using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Respondents also completed a questionnaire inquiring about risk factors for PD including caffeine consumption, tobacco use, exercise, and exposures to heavy metals, well-water, and pesticides. There was a direct relationship between olfactory performance and lifetime caffeine intake. After adjustment for age, gender, and smoking status, subjects who reported drinking 2 to 3 cups of caffeinated beverages per day (2.6 points higher 95% CI: 0.5, 4.5) and 4 or more cups per day (3.7 points higher, 95% CI: 0.6, 6.7) had significantly better UPSIT scores than those who consumed less than 1 cup per day. There was no significant relationship between olfactory performance and other risk factors. In conclusion, abnormal olfaction is associated with significantly lower lifetime caffeine consumption in first-degree relatives of PD patients. Further research is warranted to determine whether a history of lower caffeine consumption confers additional risk for the development of PD in hyposmic relatives of PD patients. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876851     DOI: 10.1002/mds.21707

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Maria Tuineaig; Josie-Anne Bertrand; Veronique Latreille; Catherine Desjardins; Jacques Y Montplaisir
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

Review 2.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

3.  Relation of risk factors and putative premotor markers for Parkinson's disease.

Authors:  I Liepelt-Scarfone; S Behnke; J Godau; K J Schweitzer; B Wolf; A Gaenslen; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

Review 4.  Smoking and olfactory dysfunction: A systematic literature review and meta-analysis.

Authors:  Gaurav S Ajmani; Helen H Suh; Kristen E Wroblewski; Jayant M Pinto
Journal:  Laryngoscope       Date:  2017-05-31       Impact factor: 3.325

Review 5.  Early Parkinson's disease and non-motor issues.

Authors:  K Ray Chaudhuri; Yogini Naidu
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

6.  Short-term effect of caffeine on olfactory function in hyposmic patients.

Authors:  Thomas Meusel; Janine Albinus; Antje Welge-Luessen; Antje Hähner; Thomas Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

7.  Risk factors and prodromal markers and the development of Parkinson's disease.

Authors:  Stefanie Lerche; Klaus Seppi; Stefanie Behnke; Inga Liepelt-Scarfone; Jana Godau; Philipp Mahlknecht; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Werner Poewe; Daniela Berg
Journal:  J Neurol       Date:  2013-11-05       Impact factor: 4.849

8.  Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Authors:  Mike A Nalls; Cory Y McLean; Jacqueline Rick; Shirley Eberly; Samantha J Hutten; Katrina Gwinn; Margaret Sutherland; Maria Martinez; Peter Heutink; Nigel M Williams; John Hardy; Thomas Gasser; Alexis Brice; T Ryan Price; Aude Nicolas; Margaux F Keller; Cliona Molony; J Raphael Gibbs; Alice Chen-Plotkin; Eunran Suh; Christopher Letson; Massimo S Fiandaca; Mark Mapstone; Howard J Federoff; Alastair J Noyce; Huw Morris; Vivianna M Van Deerlin; Daniel Weintraub; Cyrus Zabetian; Dena G Hernandez; Suzanne Lesage; Meghan Mullins; Emily Drabant Conley; Carrie A M Northover; Mark Frasier; Ken Marek; Aaron G Day-Williams; David J Stone; John P A Ioannidis; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2015-08-10       Impact factor: 44.182

9.  Physical activity and prodromal features of Parkinson disease.

Authors:  Katherine C Hughes; Xiang Gao; Samantha Molsberry; Linda Valeri; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2019-11-12       Impact factor: 9.910

Review 10.  Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.

Authors:  Honglei Chen; Edward A Burton; G Webster Ross; Xuemei Huang; Rodolfo Savica; Robert D Abbott; Alberto Ascherio; John N Caviness; Xiang Gao; Kimberly A Gray; Jau-Shyong Hong; Freya Kamel; Danna Jennings; Annette Kirshner; Cindy Lawler; Rui Liu; Gary W Miller; Robert Nussbaum; Shyamal D Peddada; Amy Comstock Rick; Beate Ritz; Andrew D Siderowf; Caroline M Tanner; Alexander I Tröster; Jing Zhang
Journal:  Environ Health Perspect       Date:  2013-08-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.